These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 18673016)

  • 1. The management of inflammation in periodontal disease.
    Van Dyke TE
    J Periodontol; 2008 Aug; 79(8 Suppl):1601-8. PubMed ID: 18673016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proresolving lipid mediators: potential for prevention and treatment of periodontitis.
    Van Dyke TE
    J Clin Periodontol; 2011 Mar; 38 Suppl 11():119-25. PubMed ID: 21323709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradigm shift in the pharmacological management of periodontal diseases.
    Hasturk H; Kantarci A; Van Dyke TE
    Front Oral Biol; 2012; 15():160-76. PubMed ID: 22142963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.
    Hamilton JA; Hasturk H; Kantarci A; Serhan CN; Van Dyke T
    Curr Atheroscler Rep; 2017 Nov; 19(12):57. PubMed ID: 29110146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proresolution mediators and receptors: novel drug targets for enhancing pharmacological armamentarium against periodontal inflammation.
    Grover V; Malhotra R; Kapoor A; Singh J; Sachdeva S
    Infect Disord Drug Targets; 2013 Feb; 13(1):75-84. PubMed ID: 23713671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of new technologies to diagnose and treat periodontal disease. A look to the future.
    Williams RC; Beck JD; Offenbacher SN
    J Clin Periodontol; 1996 Mar; 23(3 Pt 2):299-305. PubMed ID: 8707994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-resolving mediators in the regulation of periodontal disease.
    Van Dyke TE
    Mol Aspects Med; 2017 Dec; 58():21-36. PubMed ID: 28483532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-mediated resolution of inflammation in periodontal diseases.
    Kantarci A; Hasturk H; Van Dyke TE
    Periodontol 2000; 2006; 40():144-63. PubMed ID: 16398691
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipoxins and resolvins in inflammatory bowel disease.
    Weylandt KH; Kang JX; Wiedenmann B; Baumgart DC
    Inflamm Bowel Dis; 2007 Jun; 13(6):797-9. PubMed ID: 17262807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proresolving nanomedicines activate bone regeneration in periodontitis.
    Van Dyke TE; Hasturk H; Kantarci A; Freire MO; Nguyen D; Dalli J; Serhan CN
    J Dent Res; 2015 Jan; 94(1):148-56. PubMed ID: 25389003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases.
    Van Dyke TE; Serhan CN
    J Dent Res; 2003 Feb; 82(2):82-90. PubMed ID: 12562878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of inflammation in periodontitis.
    Kantarci A; Van Dyke TE
    J Periodontol; 2005 Nov; 76(11 Suppl):2168-74. PubMed ID: 16277590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin.
    El-Sharkawy H; Aboelsaad N; Eliwa M; Darweesh M; Alshahat M; Kantarci A; Hasturk H; Van Dyke TE
    J Periodontol; 2010 Nov; 81(11):1635-43. PubMed ID: 20572767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New directions in host modulation for the management of periodontal disease.
    Bhatavadekar NB; Williams RC
    J Clin Periodontol; 2009 Feb; 36(2):124-6. PubMed ID: 19207887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the host inflammatory response in periodontal disease management: exciting new directions.
    Bhatavadekar NB; Williams RC
    Int Dent J; 2009 Oct; 59(5):305-8. PubMed ID: 19998666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators.
    Serhan CN
    J Periodontol; 2008 Aug; 79(8 Suppl):1520-6. PubMed ID: 18673006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic management of periodontal diseases using systemically administered agents.
    Mariotti A; Monroe PJ
    Dent Clin North Am; 1998 Apr; 42(2):245-62. PubMed ID: 9597336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of specialized pro-resolving mediators and omega-3 polyunsaturated fatty acids in periodontal inflammation and impact on oral microbiota.
    Lee CT; Tribble GD
    Front Oral Health; 2023; 4():1217088. PubMed ID: 37559676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical innovations in managing inflammation and periodontal diseases: the workshop on inflammation and periodontal diseases.
    Genco RJ
    J Periodontol; 2008 Aug; 79(8 Suppl):1609-11. PubMed ID: 18673017
    [No Abstract]   [Full Text] [Related]  

  • 20. The design and implementation of trials of host modulation agents.
    Offenbacher S; Salvi GE; Beck JD; Williams RC
    Ann Periodontol; 1997 Mar; 2(1):199-212. PubMed ID: 9151554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.